Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model

Herpes simplex virus type 2 (HSV-2) infection affects 24 million births annually and is associated with adverse pregnancy outcomes, including neonatal herpes; however, the mechanisms underlying in utero transmission of HSV-2 are largely unknown. We examined the effects of primary HSV-2 infection dur...

Full description

Bibliographic Details
Main Authors: Allison M. Felker, Philip Nguyen, Charu Kaushic
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/10/1929
_version_ 1797512979071107072
author Allison M. Felker
Philip Nguyen
Charu Kaushic
author_facet Allison M. Felker
Philip Nguyen
Charu Kaushic
author_sort Allison M. Felker
collection DOAJ
description Herpes simplex virus type 2 (HSV-2) infection affects 24 million births annually and is associated with adverse pregnancy outcomes, including neonatal herpes; however, the mechanisms underlying in utero transmission of HSV-2 are largely unknown. We examined the effects of primary HSV-2 infection during early pregnancy on gestational outcomes in a novel, clinically relevant mouse model. Pregnant C57BL/6 mice were infected intravaginally with 10<sup>2</sup>–10<sup>5</sup> pfu/mL HSV-2 on gestation day (gd) 4.5. Controls were infected, nonpregnant, diestrus-staged mice and pregnant, uninfected mice. Compared to nonpregnant mice, pregnant mice were 100-fold more susceptible to HSV-2 infection. Three days post-inoculation (gd7.5), viral DNA was present in implantation sites, but pregnancy outcomes were largely unaffected by infection. Eight days post-inoculation (gd12.5), HSV-2 DNA persisted in placental tissues, resulting in inflammation and hemorrhage. Fetal and placental weights were reduced and fetal loss was observed with high viral doses. HSV-2 DNA and increased expression of pro-inflammatory mediators were detected in fetal tissues at gd12.5, signifying viral transmission and fetal infection, even with low viral doses. This mouse model shows a dose-dependent effect of primary HSV-2 infection on pregnancy outcomes and suggests that fetal loss may occur due to placental inflammation, thus providing valuable insight into in utero transmission of HSV-2.
first_indexed 2024-03-10T06:08:16Z
format Article
id doaj.art-2e03413e8d4647f5a3657f5e2861e8bc
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T06:08:16Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-2e03413e8d4647f5a3657f5e2861e8bc2023-11-22T20:18:12ZengMDPI AGViruses1999-49152021-09-011310192910.3390/v13101929Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse ModelAllison M. Felker0Philip Nguyen1Charu Kaushic2McMaster Immunology Research Centre, Michael G. DeGroote Centre for Learning and Discovery, McMaster University, Hamilton, ON L8S 4L8, CanadaMcMaster Immunology Research Centre, Michael G. DeGroote Centre for Learning and Discovery, McMaster University, Hamilton, ON L8S 4L8, CanadaMcMaster Immunology Research Centre, Michael G. DeGroote Centre for Learning and Discovery, McMaster University, Hamilton, ON L8S 4L8, CanadaHerpes simplex virus type 2 (HSV-2) infection affects 24 million births annually and is associated with adverse pregnancy outcomes, including neonatal herpes; however, the mechanisms underlying in utero transmission of HSV-2 are largely unknown. We examined the effects of primary HSV-2 infection during early pregnancy on gestational outcomes in a novel, clinically relevant mouse model. Pregnant C57BL/6 mice were infected intravaginally with 10<sup>2</sup>–10<sup>5</sup> pfu/mL HSV-2 on gestation day (gd) 4.5. Controls were infected, nonpregnant, diestrus-staged mice and pregnant, uninfected mice. Compared to nonpregnant mice, pregnant mice were 100-fold more susceptible to HSV-2 infection. Three days post-inoculation (gd7.5), viral DNA was present in implantation sites, but pregnancy outcomes were largely unaffected by infection. Eight days post-inoculation (gd12.5), HSV-2 DNA persisted in placental tissues, resulting in inflammation and hemorrhage. Fetal and placental weights were reduced and fetal loss was observed with high viral doses. HSV-2 DNA and increased expression of pro-inflammatory mediators were detected in fetal tissues at gd12.5, signifying viral transmission and fetal infection, even with low viral doses. This mouse model shows a dose-dependent effect of primary HSV-2 infection on pregnancy outcomes and suggests that fetal loss may occur due to placental inflammation, thus providing valuable insight into in utero transmission of HSV-2.https://www.mdpi.com/1999-4915/13/10/1929HSV-2viral infectionpregnancyplacental pathologyneonatal herpesmouse model
spellingShingle Allison M. Felker
Philip Nguyen
Charu Kaushic
Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model
Viruses
HSV-2
viral infection
pregnancy
placental pathology
neonatal herpes
mouse model
title Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model
title_full Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model
title_fullStr Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model
title_full_unstemmed Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model
title_short Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model
title_sort primary hsv 2 infection in early pregnancy results in transplacental viral transmission and dose dependent adverse pregnancy outcomes in a novel mouse model
topic HSV-2
viral infection
pregnancy
placental pathology
neonatal herpes
mouse model
url https://www.mdpi.com/1999-4915/13/10/1929
work_keys_str_mv AT allisonmfelker primaryhsv2infectioninearlypregnancyresultsintransplacentalviraltransmissionanddosedependentadversepregnancyoutcomesinanovelmousemodel
AT philipnguyen primaryhsv2infectioninearlypregnancyresultsintransplacentalviraltransmissionanddosedependentadversepregnancyoutcomesinanovelmousemodel
AT charukaushic primaryhsv2infectioninearlypregnancyresultsintransplacentalviraltransmissionanddosedependentadversepregnancyoutcomesinanovelmousemodel